Clover Health Investments (CLOV) Expected to Announce Quarterly Earnings on Wednesday

Clover Health Investments (NASDAQ:CLOV) is projected to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.0038) per share and revenue of $740.31 million for the quarter. Investors may visit the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 5:00 PM ET.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The company had revenue of $743.17 million during the quarter, compared to the consensus estimate of $728.27 million. On average, analysts expect Clover Health Investments to post $0.06 EPS for the current fiscal year and $0.17 EPS for the next fiscal year.

Clover Health Investments Price Performance

Shares of CLOV opened at $4.63 on Wednesday. Clover Health Investments has a twelve month low of $1.58 and a twelve month high of $5.59. The firm has a 50 day moving average of $4.48 and a 200 day moving average of $3.51.

Analyst Ratings Changes

CLOV has been the subject of a number of research analyst reports. Zacks Research upgraded shares of Clover Health Investments to a “hold” rating in a research note on Monday, September 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Clover Health Investments in a research report on Monday, September 21st. UBS Group increased their price objective on shares of Clover Health Investments from $4.75 to $5.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Canaccord Genuity Group raised their target price on shares of Clover Health Investments from $4.20 to $5.50 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Finally, Wall Street Zen downgraded shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Clover Health Investments has an average rating of “Hold” and a consensus price target of $4.75.

Insider Activity

In related news, VP Joseph Frank Oldakowski sold 20,000 shares of Clover Health Investments stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $5.16, for a total transaction of $103,200.00. Following the sale, the vice president owned 279,067 shares of the company’s stock, valued at approximately $1,439,985.72. This trade represents a 6.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Andrew Toy sold 318,806 shares of Clover Health Investments stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $4.19, for a total transaction of $1,335,797.14. Following the sale, the chief executive officer owned 9,140,510 shares in the company, valued at approximately $38,298,736.90. The trade was a 3.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 856,371 shares of company stock valued at $3,870,740. Company insiders own 23.51% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. is a health insurance technology company focused on providing Medicare Advantage plans to eligible seniors in the United States. Its plans combine hospital, medical and prescription drug coverage with additional benefits that may vary by plan and location.

The company uses its Clover Assistant technology platform to provide physicians with data-driven insights intended to support clinical decision-making and care coordination. The platform aggregates member health information and helps participating providers identify care opportunities, manage chronic conditions and engage with patients.

Clover Health was founded in 2012 and became a publicly traded company in 2021 through a merger with a special purpose acquisition company.